SG11201702202UA - Aqueous composition - Google Patents
Aqueous compositionInfo
- Publication number
- SG11201702202UA SG11201702202UA SG11201702202UA SG11201702202UA SG11201702202UA SG 11201702202U A SG11201702202U A SG 11201702202UA SG 11201702202U A SG11201702202U A SG 11201702202UA SG 11201702202U A SG11201702202U A SG 11201702202UA SG 11201702202U A SG11201702202U A SG 11201702202UA
- Authority
- SG
- Singapore
- Prior art keywords
- aqueous composition
- aqueous
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014194679 | 2014-09-25 | ||
| PCT/JP2015/077013 WO2016047719A1 (en) | 2014-09-25 | 2015-09-25 | Aqueous composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201702202UA true SG11201702202UA (en) | 2017-04-27 |
Family
ID=55581238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201702202UA SG11201702202UA (en) | 2014-09-25 | 2015-09-25 | Aqueous composition |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10376523B2 (en) |
| EP (1) | EP3199160B1 (en) |
| JP (5) | JP6236166B2 (en) |
| KR (1) | KR101830588B1 (en) |
| CN (1) | CN106714806B (en) |
| BR (1) | BR112017006150A2 (en) |
| CA (1) | CA2962562A1 (en) |
| DK (1) | DK3199160T3 (en) |
| ES (1) | ES2779314T3 (en) |
| HU (1) | HUE048790T2 (en) |
| MX (1) | MX2017003941A (en) |
| MY (1) | MY177032A (en) |
| PL (1) | PL3199160T3 (en) |
| PT (1) | PT3199160T (en) |
| SG (1) | SG11201702202UA (en) |
| TW (1) | TWI668215B (en) |
| WO (1) | WO2016047719A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201702298VA (en) * | 2014-09-25 | 2017-04-27 | Kowa Co | Pharmaceutical preparation |
| CN113262226B (en) * | 2021-04-19 | 2023-05-16 | 杭州市第一人民医院 | Application of Li Shude mol in preparation of bacterial infection treatment drugs |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4212149B2 (en) | 1998-06-11 | 2009-01-21 | 株式会社デ・ウエスタン・セラピテクス研究所 | Medicine |
| JPWO2005108446A1 (en) | 2004-05-07 | 2008-03-21 | 旭硝子株式会社 | Fluorine-containing copolymer, method for producing the same, and resist composition containing the same |
| TWI367098B (en) | 2004-12-23 | 2012-07-01 | Kowa Co | Treating agent for glaucoma |
| US20060142270A1 (en) | 2004-12-23 | 2006-06-29 | Kowa Co., Ltd. | Preventing or treating agent for glaucoma |
| WO2006115244A1 (en) | 2005-04-25 | 2006-11-02 | D. Western Therapeutics Institute, Inc. | 4-bromoisoquinoline derivative and pharmaceutical preparation comprising the same |
| JP2006348028A (en) * | 2005-05-19 | 2006-12-28 | Kowa Co | Prophylactic or curative agent for glaucoma |
| WO2006137368A1 (en) * | 2005-06-21 | 2006-12-28 | Kowa Co., Ltd. | Preventive or remedy for glaucoma |
| PL1905452T3 (en) * | 2005-07-12 | 2013-11-29 | Kowa Co | Agent for prevention or treatment of glaucoma |
| US7867999B1 (en) * | 2005-12-22 | 2011-01-11 | Alcon Research, Ltd. | Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-mediated diseases and conditions |
| US20080064681A1 (en) | 2006-09-11 | 2008-03-13 | Hiroyoshi Hidaka | Therapeutic agent for treating glaucoma |
| CA2878370C (en) | 2012-07-13 | 2021-01-19 | Santen Pharmaceutical Co., Ltd. | Combinations comprising a sulfonamide compound for the treatment of glaucoma or ocular hypertension |
| EP3626245B1 (en) | 2013-04-24 | 2021-05-05 | Kyushu University, National University Corporation | Therapeutic agent for eyeground disease |
-
2015
- 2015-09-25 US US15/514,259 patent/US10376523B2/en not_active Expired - Fee Related
- 2015-09-25 CN CN201580051331.0A patent/CN106714806B/en active Active
- 2015-09-25 PT PT158440479T patent/PT3199160T/en unknown
- 2015-09-25 KR KR1020177006791A patent/KR101830588B1/en active Protection Beyond IP Right Term
- 2015-09-25 TW TW104131861A patent/TWI668215B/en active
- 2015-09-25 CA CA2962562A patent/CA2962562A1/en not_active Abandoned
- 2015-09-25 PL PL15844047T patent/PL3199160T3/en unknown
- 2015-09-25 DK DK15844047.9T patent/DK3199160T3/en active
- 2015-09-25 MY MYPI2017700943A patent/MY177032A/en unknown
- 2015-09-25 HU HUE15844047A patent/HUE048790T2/en unknown
- 2015-09-25 JP JP2016550376A patent/JP6236166B2/en active Active
- 2015-09-25 ES ES15844047T patent/ES2779314T3/en active Active
- 2015-09-25 MX MX2017003941A patent/MX2017003941A/en unknown
- 2015-09-25 EP EP15844047.9A patent/EP3199160B1/en active Active
- 2015-09-25 SG SG11201702202UA patent/SG11201702202UA/en unknown
- 2015-09-25 BR BR112017006150A patent/BR112017006150A2/en not_active Application Discontinuation
- 2015-09-25 WO PCT/JP2015/077013 patent/WO2016047719A1/en active Application Filing
-
2017
- 2017-10-26 JP JP2017207302A patent/JP2018012736A/en not_active Ceased
-
2019
- 2019-08-21 JP JP2019150783A patent/JP2019194273A/en active Pending
-
2021
- 2021-05-06 JP JP2021078649A patent/JP2021143179A/en active Pending
-
2023
- 2023-01-31 JP JP2023012895A patent/JP2023052791A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PT3199160T (en) | 2020-04-08 |
| CN106714806B (en) | 2020-03-03 |
| ES2779314T3 (en) | 2020-08-14 |
| EP3199160A1 (en) | 2017-08-02 |
| MX2017003941A (en) | 2017-06-26 |
| DK3199160T3 (en) | 2020-04-20 |
| JP6236166B2 (en) | 2017-11-22 |
| JP2021143179A (en) | 2021-09-24 |
| EP3199160B1 (en) | 2020-03-11 |
| JP2023052791A (en) | 2023-04-12 |
| CA2962562A1 (en) | 2016-03-31 |
| JPWO2016047719A1 (en) | 2017-06-29 |
| US20170290841A1 (en) | 2017-10-12 |
| JP2019194273A (en) | 2019-11-07 |
| KR101830588B1 (en) | 2018-02-20 |
| KR20170063565A (en) | 2017-06-08 |
| TWI668215B (en) | 2019-08-11 |
| WO2016047719A1 (en) | 2016-03-31 |
| JP2018012736A (en) | 2018-01-25 |
| PL3199160T3 (en) | 2020-07-27 |
| EP3199160A4 (en) | 2018-04-25 |
| CN106714806A (en) | 2017-05-24 |
| HUE048790T2 (en) | 2020-09-28 |
| US10376523B2 (en) | 2019-08-13 |
| MY177032A (en) | 2020-09-02 |
| TW201619147A (en) | 2016-06-01 |
| BR112017006150A2 (en) | 2017-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201704737SA (en) | Novel aqueous composition | |
| SG11201704735WA (en) | Composition | |
| SG11201704740WA (en) | Aqueous composition | |
| HK1218859A1 (en) | Composition | |
| HK1214967A1 (en) | Composition | |
| LT3216451T (en) | Ophthalmic aqueous composition | |
| GB201403017D0 (en) | Composition | |
| HK1244432A1 (en) | Composition | |
| GB201414910D0 (en) | Composition | |
| ZA201704464B (en) | Composition | |
| GB201403561D0 (en) | Composition | |
| GB201414555D0 (en) | Composition | |
| HK1226296A1 (en) | Retinoic-acid-producing agent | |
| SG11201702202UA (en) | Aqueous composition | |
| GB201519442D0 (en) | Composition | |
| GB201410493D0 (en) | Composition | |
| ZA201606127B (en) | Composition | |
| GB201420628D0 (en) | Composition | |
| GB201415483D0 (en) | Composition | |
| GB201404390D0 (en) | Composition | |
| GB201402648D0 (en) | Composition | |
| IL250781A0 (en) | Composition | |
| GB201503484D0 (en) | Composition | |
| GB201502355D0 (en) | Composition | |
| GB201421660D0 (en) | Composition |